# Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

> **NCT00480896** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 250 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** tacrolimus ointment
- **DRUG:** Placebo ointment

## Key facts

- **NCT ID:** NCT00480896
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2014-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480896, "Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00480896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*